The stock of Outset Medical Inc (NASDAQ: OM) has decreased by -14.03 when compared to last closing price of 0.58.Despite this, the company has seen a loss of -14.33% in its stock price over the last five trading days. globenewswire.com reported 2025-03-18 that SAN JOSE, Calif., March 18, 2025 (GLOBE NEWSWIRE) — Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced a one-for-fifteen reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001, which will become effective at 12:01 a.m. Eastern Time on Thursday, March 20, 2025. The Company’s common stock will continue to trade under Outset’s existing trading symbol, OM, on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis when the market opens on Thursday, March 20, 2025, with the new CUSIP number 690145206.
Is It Worth Investing in Outset Medical Inc (NASDAQ: OM) Right Now?
The 36-month beta value for OM is at 2.04. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 0 rating it as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for OM is 47.06M, and currently, shorts hold a 23.86% of that float. The average trading volume for OM on March 18, 2025 was 1.11M shares.
OM’s Market Performance
OM’s stock has seen a -14.33% decrease for the week, with a -44.72% drop in the past month and a -58.93% fall in the past quarter. The volatility ratio for the week is 9.76%, and the volatility levels for the past 30 days are at 13.90% for Outset Medical Inc The simple moving average for the past 20 days is -27.91% for OM’s stock, with a -67.51% simple moving average for the past 200 days.
Analysts’ Opinion of OM
Many brokerage firms have already submitted their reports for OM stocks, with RBC Capital Mkts repeating the rating for OM by listing it as a “Sector Perform.” The predicted price for OM in the upcoming period, according to RBC Capital Mkts is $3 based on the research report published on August 08, 2024 of the previous year 2024.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see OM reach a price target of $6, previously predicting the price at $5. The rating they have provided for OM stocks is “Outperform” according to the report published on June 21st, 2024.
BTIG Research gave a rating of “Buy” to OM, setting the target price at $6 in the report published on April 08th of the previous year.
OM Trading at -37.69% from the 50-Day Moving Average
After a stumble in the market that brought OM to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.48% of loss for the given period.
Volatility was left at 13.90%, however, over the last 30 days, the volatility rate increased by 9.76%, as shares sank -44.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.91% lower at present.
During the last 5 trading sessions, OM fell by -13.08%, which changed the moving average for the period of 200-days by -86.73% in comparison to the 20-day moving average, which settled at $0.6898. In addition, Outset Medical Inc saw -55.23% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at OM starting from Trigg Leslie, who sale 14,611 shares at the price of $0.90 back on Feb 18 ’25. After this action, Trigg Leslie now owns 880,969 shares of Outset Medical Inc, valued at $13,150 using the latest closing price.
Nash Marc, the SVP Operations and R&D of Outset Medical Inc, sale 4,204 shares at $0.90 during a trade that took place back on Feb 18 ’25, which means that Nash Marc is holding 200,764 shares at $3,784 based on the most recent closing price.
Stock Fundamentals for OM
Current profitability levels for the company are sitting at:
- -1.0 for the present operating margin
- 0.34 for the gross margin
The net margin for Outset Medical Inc stands at -1.13. The total capital return value is set at -0.49. Equity return is now at value -170.97, with -43.41 for asset returns.
Based on Outset Medical Inc (OM), the company’s capital structure generated 0.14 points at debt to capital in total, while cash flow to debt ratio is standing at -25.94. The debt to equity ratio resting at 0.17. The interest coverage ratio of the stock is -4.75.
Currently, EBITDA for the company is -97.89 million with net debt to EBITDA at 1.2. When we switch over and look at the enterprise to sales, we see a ratio of -0.81. The receivables turnover for the company is 3.19for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.69.
Conclusion
In conclusion, Outset Medical Inc (OM) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
